Loading...
Escitalopram
India Pharmaceutical Trade Intelligence
Who Supplies Escitalopram to India from MALTA
India's escitalopram imports from MALTA total $9.8K across 35 shipments from 5 foreign suppliers. ACTAVIS LIMITED leads with $9.1K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for escitalopram — a diversified sourcing base with multiple active suppliers from MALTA.
Top foreign suppliers (MALTA) — Ranked by import value
ACTAVIS LIMITED is the leading Escitalopram supplier from MALTA to India, with import value of $9.1K across 30 shipments. The top 5 suppliers — ACTAVIS LIMITED, ACTAVIS LIMITED, BLB016, ACTAVIS LIMITED,, M/S APL SWIFT SERVICES (MALTA) LTD, MS APL SWIFT SERVICES (MALTA) LIMITED — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (MALTA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS LIMITED | $9.1K | 30 | 93.4% |
| 2 | ACTAVIS LIMITED, BLB016 | $343 | 1 | 3.5% |
| 3 | ACTAVIS LIMITED, | $259 | 1 | 2.7% |
| 4 | M/S APL SWIFT SERVICES (MALTA) LTD | $25 | 2 | 0.3% |
| 5 | MS APL SWIFT SERVICES (MALTA) LIMITED | $14 | 1 | 0.1% |
Showing top 5 of 5 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from MALTA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $9.7K | 32 | 99.6% |
| 2 | AUROBINDO PHARMA LTD | $25 | 2 | 0.3% |
| 3 | AUROBINDO PHARMA LIMITED | $14 | 1 | 0.1% |
Import Statistics
- Import Value
- $9.8K
- Shipments
- 35
- Foreign Suppliers
- 5
- Indian Buyers
- 3
- Avg. Shipment
- $279
Other Escitalopram Import Origins
Related Analysis
Frequently Asked Questions — Escitalopram Imports from MALTA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Escitalopram suppliers from MALTA to India?
The top Escitalopram suppliers from MALTA to India include ACTAVIS LIMITED, ACTAVIS LIMITED, BLB016, ACTAVIS LIMITED,. The leading supplier is ACTAVIS LIMITED with import value of $9.1K USD across 30 shipments. India imported Escitalopram worth $9.8K USD from MALTA in total across 35 shipments.
QHow much Escitalopram does India import from MALTA?
India imported Escitalopram worth $9.8K USD from MALTA across 35 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Escitalopram from MALTA?
The main Indian buyers of Escitalopram sourced from MALTA include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED. The largest buyer is ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED with $9.7K in imports across 32 shipments.
QWhat is the total value of Escitalopram imports from MALTA to India?
The total value of Escitalopram imports from MALTA to India is $9.8K USD, across 35 shipments and 5 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: MALTA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Escitalopram.
- 2.Supplier/Buyer Matching: 5 foreign suppliers from MALTA and 3 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $9.8K aggregated from 35 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
35 Verified Shipments
5 suppliers, 3 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists